rs2738465

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000527.5(LDLR):​c.*504G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.292 in 460,304 control chromosomes in the GnomAD database, including 20,748 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.29 ( 6748 hom., cov: 31)
Exomes 𝑓: 0.29 ( 14000 hom. )

Consequence

LDLR
NM_000527.5 3_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.77

Publications

21 publications found
Variant links:
Genes affected
LDLR (HGNC:6547): (low density lipoprotein receptor) The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. The encoded protein is normally bound at the cell membrane, where it binds low density lipoprotein/cholesterol and is taken into the cell. Lysosomes release the cholesterol, which is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2022]
SPC24 (HGNC:26913): (SPC24 component of NDC80 kinetochore complex) Predicted to be involved in cell division. Located in nucleolus and nucleoplasm. Part of Ndc80 complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 19-11131820-G-A is Benign according to our data. Variant chr19-11131820-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 328064.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.474 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LDLRNM_000527.5 linkc.*504G>A 3_prime_UTR_variant Exon 18 of 18 ENST00000558518.6 NP_000518.1 P01130-1A0A024R7D5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LDLRENST00000558518.6 linkc.*504G>A 3_prime_UTR_variant Exon 18 of 18 1 NM_000527.5 ENSP00000454071.1 P01130-1

Frequencies

GnomAD3 genomes
AF:
0.293
AC:
44402
AN:
151752
Hom.:
6735
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.283
Gnomad AMI
AF:
0.322
Gnomad AMR
AF:
0.276
Gnomad ASJ
AF:
0.277
Gnomad EAS
AF:
0.491
Gnomad SAS
AF:
0.286
Gnomad FIN
AF:
0.246
Gnomad MID
AF:
0.244
Gnomad NFE
AF:
0.296
Gnomad OTH
AF:
0.280
GnomAD4 exome
AF:
0.292
AC:
90098
AN:
308434
Hom.:
14000
Cov.:
0
AF XY:
0.290
AC XY:
46949
AN XY:
162030
show subpopulations
African (AFR)
AF:
0.268
AC:
2552
AN:
9514
American (AMR)
AF:
0.286
AC:
3185
AN:
11148
Ashkenazi Jewish (ASJ)
AF:
0.275
AC:
2698
AN:
9796
East Asian (EAS)
AF:
0.492
AC:
9391
AN:
19106
South Asian (SAS)
AF:
0.263
AC:
8934
AN:
33946
European-Finnish (FIN)
AF:
0.253
AC:
4399
AN:
17420
Middle Eastern (MID)
AF:
0.226
AC:
310
AN:
1374
European-Non Finnish (NFE)
AF:
0.284
AC:
53501
AN:
188128
Other (OTH)
AF:
0.285
AC:
5128
AN:
18002
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
2833
5666
8500
11333
14166
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
360
720
1080
1440
1800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.293
AC:
44453
AN:
151870
Hom.:
6748
Cov.:
31
AF XY:
0.290
AC XY:
21528
AN XY:
74240
show subpopulations
African (AFR)
AF:
0.283
AC:
11735
AN:
41406
American (AMR)
AF:
0.277
AC:
4223
AN:
15230
Ashkenazi Jewish (ASJ)
AF:
0.277
AC:
962
AN:
3468
East Asian (EAS)
AF:
0.490
AC:
2524
AN:
5148
South Asian (SAS)
AF:
0.286
AC:
1370
AN:
4792
European-Finnish (FIN)
AF:
0.246
AC:
2600
AN:
10584
Middle Eastern (MID)
AF:
0.252
AC:
74
AN:
294
European-Non Finnish (NFE)
AF:
0.296
AC:
20086
AN:
67930
Other (OTH)
AF:
0.278
AC:
587
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1570
3141
4711
6282
7852
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
460
920
1380
1840
2300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.292
Hom.:
9694
Bravo
AF:
0.297
Asia WGS
AF:
0.360
AC:
1250
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hypercholesterolemia, familial, 1 Benign:2
-
Department of Human Genetics, Laborarztpraxis Dres. Walther, Weindel und Kollegen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Due to the increased occurrence of the mutation (>= 5%), this variant is classified as likely benign. -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Familial hypercholesterolemia Benign:1
Jun 30, 2022
GENinCode PLC
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.46
DANN
Benign
0.59
PhyloP100
-1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2738465; hg19: chr19-11242496; API